Condition
Cancer, Ovarian
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 6 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownInterventions to Decrease Financial ToxicityNCT05939440 · 2022-06-01
COMPLETEDQuest to Analyze One Thousand Humans MeditatingNCT06583395 · 2021-12-05
ENROLLING_BY_INVITATIONFamily History App in Personalized MedicineNCT04726319 · 2021-09-20
COMPLETEDHigh Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower LimbsNCT03653819 · 2018-09-06
COMPLETEDExercise Effect on Chemotherapy-Induced Neuropathic PainNCT02991677 · 2018-03-01
UNKNOWNComparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus BiosimilarsNCT04971304 · 2015-03-01
COMPLETEDCommon interventions
Advanced multi-component meditation practiceBEHAVIORAL1aerobic exercise interventionBEHAVIORAL1control groupOTHER1FHAMe InterventionOTHER1First exercise session - compressionOTHER1First exercise session + compressionOTHER1Proactive Cost of Care (P-COC) interventionOTHER1Receipt of granulocyte-colony stimulating factorDRUG1resistive trainingBEHAVIORAL1Usual CareOTHER1
Leading sponsors
Trial status mix
COMPLETED4
ENROLLING_BY_INVITATION1
UNKNOWN1
Phase mix
NA4
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.